tDCS and Speech Therapy in Aphasia Treatment: A Multicenter Comparative Study of Efficacy
Medical Science Monitor · 2025
DOI: 10.12659/msm.950237 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Medical Science Monitor, 2025. Verfasst von Zofia Twardochleb und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Neurorehabilitation, AFA-MED, Łódź, Poland. Hauptthemen laut MEDLINE: Transcranial Direct Current Stimulation, Aphasia, Speech Therapy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND Aphasia is a common consequence of stroke and traumatic brain injury (TBI) that significantly impairs communication and quality of life. Transcranial direct current stimulation (tDCS) has emerged as a non-invasive technique potentially enhancing language rehabilitation. This study aimed to evaluate the efficacy of tDCS in combination with speech-language therapy (SLT) in improving language functions in patients with aphasia. MATERIAL AND METHODS A group of 90 patients diagnosed with TBI- or stroke-related aphasia were randomly assigned to 3 groups: tDCS alone (Group I), SLT alone (Group II), and tDCS combined with SLT (Group III). Treatment procedures spanned 5 months. tDCS sessions lasted 30-40 minutes each (1-1.5 mA), targeting the left dorsolateral (F3) and the right (F4) prefrontal cortex. Language function was assessed using the Frenchay Aphasia Screening Test (FAST), Aphasia Evaluation Scale (SODA), and Token Test (TT). Statistical analyses compared pre- and post-intervention outcomes within and between groups. RESULTS All groups demonstrated significant improvements in language function (p < 0.001). Group III showed the greatest gains in verbal expression, comprehension, and reading (32.6% improvement in FAST scores), significantly outperforming Group I (24.3%) and Group II (17.8%). tDCS alone was more effective than SLT alone (p = 0.04). Combining tDCS with SLT resulted in superior patient-reported improvements in daily communication and confidence in verbal expression compared to either treatment alone. CONCLUSIONS Patients who received combined tDCS and SLT had notable improvements across all measured parameters, including verbal expression, comprehension, reading, and writing, as assessed by the FAST, SODA, and TT tests.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Centre of Neurorehabilitation, AFA-MED, Łódź, Poland.
- Department of Neurosurgery, University Centre of Neurology and Neurosurgery, Wrocław Medical University, Wrocław, Poland.
- Faculty of Medicine, Wrocław University of Science and Technology, Wrocław, Poland.
- Department of Neurosurgery, Provincial Specialist Hospital in Legnica, Legnica, Poland.
- Division of Clinical Physiotherapy and Rehabilitation, University Centre of Physiotherapy and Rehabilitation, Faculty of Physiotherapy, Wrocław Medical University, Wrocław, Poland.
- Department of Neurological Rehabilitation, Regional Specialist Hospital in Wrocław, Wrocław, Poland.
ORCID-Profile: Zofia Twardochleb, Marta Szczepańska, Maciej M Miś, Marcin Miś, Adam Druszcz, Małgorzata Paprocka-Borowicz, Joanna Rosińczuk
Zitieren
APA
Twardochleb, Z., Szczepańska, M., Miś, M. M., Miś, M., Druszcz, A., Paprocka-Borowicz, M., & Rosińczuk, J. (2025). tDCS and Speech Therapy in Aphasia Treatment: A Multicenter Comparative Study of Efficacy. Medical Science Monitor. https://doi.org/10.12659/msm.950237
Vancouver
Twardochleb Z, Szczepańska M, Miś MM, Miś M, Druszcz A, Paprocka-Borowicz M, et al. tDCS and Speech Therapy in Aphasia Treatment: A Multicenter Comparative Study of Efficacy. Medical Science Monitor. 2025. doi:10.12659/msm.950237
BibTeX
@article{Twardochleb2025,
author = {Twardochleb, Zofia and Szczepańska, Marta and Miś, Maciej M and Miś, Marcin and Druszcz, Adam and Paprocka-Borowicz, Małgorzata and Rosińczuk, Joanna},
title = {tDCS and Speech Therapy in Aphasia Treatment: A Multicenter Comparative Study of Efficacy},
journal = {Medical Science Monitor},
year = {2025},
doi = {10.12659/msm.950237}
}
EUVIMED